Open AccessPhase I study of MLN8237—investigational Aurora A kinase inhibitor—in relapsed/refractory multiple myeloma, Non-Hodgkin lymphoma and chronic lymphocytic leukemia
Author(s) -
Kevin R. Kelly,
Thomas C. Shea,
André Goy,
Jesús G. Berdeja,
Craig B. Reeder,
Kevin T. McDonagh,
Xiaofei Zhou,
Hadi Danaee,
Hua Liu,
Jeffrey Ecsedy,
Huifeng Niu,
Ely Benaim,
Swaminathan P. Iyer
Publication year - 2014
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/4j0t-1728
Subject(s) - chronic lymphocytic leukemia , medicine , refractory (planetary science) , lymphoma , multiple myeloma , hodgkin lymphoma , leukemia , cancer research , oncology , biology , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom